1
Total Mentions
1
Documents
0
Connected Entities
Name reference in documents
EFTA01473355
nal growth rate. Risks: 1) Base business sales risk, 2) Sparsentan / other pipeline products fail, 3) Regulatory risk, and 4) Reimbursement risk. Evan Seigerman Research Associate Research Associate Key changes EFTA01473355 Price target EPS (USD) Date 27 May 2015 Breaking News Price at 26 May 2015
No connected entities